We also conducted an as treated analysis assessing only active treatment from first initiation until first break of treatment, where cohort members were followed from index date until first registration of suicide or suicide attempts, emigration, death, switching to the other study drug or reaching the end of their first treatment period
Because GLP-1s are intended to be used alongside lifestyle changes, pairing medication with nutrition, behavior change, and metabolic health support may help employers maximize the value of these medications
Risks and Considerations When Using GLP-1 Like all medications, GLP-1 receptor agonists carry potential adverse effects that patients and prescribers must consider carefully
Many patients find that the appetite-suppressing effects of semaglutide make it easier to adopt healthier eating patterns that naturally support lipid improvement
Semaglutide is a glucagon-like peptide 1 (GLP-1) medication whose shortage has been in effect since 2022